TCM
PFE icon

Telos Capital Management’s Pfizer PFE Stock Holding History

Telos Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$625K Buy
25,954
+174
+0.7% +$4.55K 0.06% 139
2026
Q1 		$724K Sell
25,780
-208
-0.8% -$5.54K 0.07% 133
2025
Q4 		$647K Sell
25,988
-291
-1% -$7.34K 0.06% 139
2025
Q3 		$670K Sell
26,279
-1,121
-4% -$27.7K 0.06% 136
2025
Q2 		$664K Buy
27,400
+2,314
+9% +$54K 0.07% 137
2025
Q1 		$636K Buy
25,086
+1,794
+8% +$46.9K 0.07% 134
2024
Q4 		$618K Buy
23,292
+1,739
+8% +$47.2K 0.07% 136
2024
Q3 		$624K Buy
21,553
+397
+2% +$11.6K 0.07% 136
2024
Q2 		$592K Sell
21,156
-509
-2% -$14K 0.07% 136
2024
Q1 		$601K Sell
21,665
-21,634
-50% -$600K 0.07% 137
2023
Q4 		$1.25M Sell
43,299
-2,564
-6% -$77.5K 0.15% 107
2023
Q3 		$1.52M Sell
45,863
-44
-0.1% -$1.56K 0.21% 91
2023
Q2 		$1.68M Buy
45,907
+2,587
+6% +$101K 0.22% 92
2023
Q1 		$1.77M Sell
43,320
-1,385
-3% -$59.8K 0.25% 91
2022
Q4 		$2.29M Sell
44,705
-5,060
-10% -$243K 0.33% 84
2022
Q3 		$2.18M Sell
49,765
-5,052
-9% -$245K 0.36% 81
2022
Q2 		$2.87M Buy
54,817
+1,018
+2% +$51.9K 0.44% 76
2022
Q1 		$2.79M Sell
53,799
-345
-0.6% -$17.9K 0.36% 83
2021
Q4 		$3.2M Buy
54,144
+119
+0.2% +$5.9K 0.4% 80
2021
Q3 		$2.32M Sell
54,025
-2,216
-4% -$98.2K 0.32% 89
2021
Q2 		$2.2M Sell
56,241
-7,866
-12% -$306K 0.29% 91
2021
Q1 		$2.32M Sell
64,107
-1,515
-2% -$53.8K 0.33% 90
2020
Q4 		$2.42M Sell
65,622
-1,286
-2% -$47.2K 0.37% 84
2020
Q3 		$2.33M Sell
66,908
-8,543
-11% -$300K 0.41% 82
2020
Q2 		$2.34M Sell
75,451
-2,713
-3% -$92.2K 0.45% 74
2020
Q1 		$2.42M Buy
78,164
+37,727
+93% +$1.29M 0.6% 63
2019
Q4 		$1.5M Buy
40,437
+10,217
+34% +$364K 0.34% 84
2019
Q3 		$1.03M Buy
30,220
+12,885
+74% +$469K 0.28% 90
2019
Q2 		$713K Buy
17,335
+843
+5% +$33.5K 0.21% 95
2019
Q1 		$665K Sell
16,492
-40
-0.2% -$1.6K 0.21% 97
2018
Q4 		$685K Buy
16,532
+1,203
+8% +$49.9K 0.25% 89
2018
Q3 		$641K Buy
15,329
+2,410
+19% +$92.8K 0.21% 100
2018
Q2 		$445K Buy
12,919
+4,725
+58% +$161K 0.15% 112
2018
Q1 		$276K Buy
8,194
+492
+6% +$16.9K 0.1% 129
2017
Q4 		$265K Buy
+7,702
New +$263K 0.09% 134
2017
Q2 		– Sell
-7,603
Closed -$247K – 149
2017
Q1 		$247K Sell
7,603
-5,322
-41% -$168K 0.1% 127
2016
Q4 		$398K Buy
12,925
+923
+8% +$28.2K 0.18% 110
2016
Q3 		$386K Hold
12,002
– – 0.18% 110
2016
Q2 		$401K Sell
12,002
-1,821
-13% -$58.1K 0.2% 108
2016
Q1 		$389K Sell
13,823
-2,560
-16% -$73.1K 0.2% 105
2015
Q4 		$502K Buy
16,383
+1,622
+11% +$51K 0.27% 97
2015
Q3 		$440K Buy
14,761
+2,213
+18% +$71K 0.27% 100
2015
Q2 		$399K Buy
12,548
+4,269
+52% +$139K 0.22% 107
2015
Q1 		$273K Sell
8,279
-1,913
-19% -$60.8K 0.16% 121
2014
Q4 		$301K Sell
10,192
-1,144
-10% -$32.8K 0.18% 117
2014
Q3 		$318K Buy
11,336
+583
+5% +$16.4K 0.2% 122
2014
Q2 		$303K Sell
10,753
-181
-2% -$5.16K 0.19% 125
2014
Q1 		$333K Buy
10,934
+878
+9% +$26.2K 0.23% 118
2013
Q4 		$292K Buy
10,056
+236
+2% +$6.87K 0.21% 122
2013
Q3 		$268K Buy
9,820
+1,872
+24% +$50.9K 0.22% 118
2013
Q2 		$211K Buy
+7,948
New +$220K 0.19% 122

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Telos Capital Management's PFE Position: Q2 2026 in Review

Telos Capital Management increased its Pfizer (PFE) stake by 0.67% in Q2 2026, buying an estimated $4.55K and bringing the position to 25,954 shares worth $625K. The position accounts for 0.06% of the portfolio, ranked #139.

Telos Capital Management first reported a position in PFE in Q2 2013 and has held it in 51 quarters since. The position peaked at $3.2M in Q4 2021. 990 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Telos Capital Management held 25,954 shares of Pfizer worth $625K as of Q2 2026.
  • Telos Capital Management bought 174 Pfizer shares in Q2 2026, an estimated $4.55K.
  • Pfizer made up 0.06% of Telos Capital Management's portfolio in Q2 2026, its #139 holding.
  • Telos Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 51 quarters since.
  • Telos Capital Management's Pfizer position peaked at $3.2M in Q4 2021.
  • 990 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Telos Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.